Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results-Reference-Cited by-同舟云学术

Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results

Published:2021-06-26 Issue:18 Volume:9 Page:4559-4572
ISSN:2307-8960
Container-title:World Journal of Clinical Cases
language:
Short-container-title:WJCC

Author:

Adhoute Xavier,Larrey Edouard,Anty Rodolphe,Chevallier Patrick,Penaranda Guillaume,Tran Albert,Bronowicki Jean-Pierre,Raoul Jean-Luc,Castellani Paul,Perrier Hervé,Bayle Olivier,Monnet Olivier,Pol Bernard,Bourliere Marc

Publisher

Baishideng Publishing Group Inc.

Subject

General Medicine

Reference30 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Management of hepatocellular carcinoma

3. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy

4. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

5. Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis;World Journal of Methodology;2023-09-20

2. FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE;Frontiers in Medicine;2023-05-02

3. A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma;Journal of Personalized Medicine;2022-08-25

4. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems;Frontiers in Oncology;2022-02-23